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A paradigm shift several decades ago elucidated that
aggressive periodontitis (AgP) was not a degenerative
disorder but a rapid progressive form of plaque-induced
inflammatory periodontal disease. Ensuing years of research
have led to linkage analysis identification of specific genetic
defects responsible for AgP in some families and to the
finding that subgingival detection of A. actinomycet-
emcomitans JP2 clone is a predictive factor for disease onset
and progression. However, rather disappointingly, these
‘proven’ risk factors are only detected in a small subset of AgP
cases. Recent advances are leading to a new paradigm shift,
with the realization that genetically-driven dysbiotic changes
in the subgingival microbiota may predispose to a cascade of
events leading to the rapid periodontal tissue destruction
seen in AgP. This review tries to dissect the existing literature
on the host response-microbial axis of AgP and to propose
possible pathogenic pathways in line with current theories.
Introduction
In 1999, the American Academy of Periodontology (AAP)
introduced the controversial term “Aggressive Periodontitis”
(AgP) to define a group of destructive periodontal diseases with a
rapid progression.1 This definition aimed to encompass previous
definitions of early-onset periodontitis, juvenile periodontitis and
rapidly progressive periodontitis, using a terminology
(“aggressive”) rather unusual in the medical field. This put the
emphasis on rapidity of progression (rather than necessarily on
age of onset) and perhaps on the difficulty of treating it. Along
with rapid progression, systemic health and familial aggregation
were considered the main features, following concepts already
described three decades earlier.2 Among other secondary features,
a microbiological element was introduced, in theory to help in
the differential diagnosis with the more common chronic peri-
odontitis (CP). The authors of the consensus statement reported
that “elevated proportions of Actinobacillus actinomycetemcomi-
tans (now Aggregatibacter actinomycetemcomitans) and in certain
populations of Porphyromonas gingivalis” were typical of AgP.1
This reflects the enormous efforts of previous decades to identify
a microbiological culprit able to cause rapidly progressive peri-
odontitis in young and healthy individuals. Identification of a
specific disease-initiating microbe would help in the diagnosis
and treatment of AgP, targeted at the elimination of the responsi-
ble pathogen. On the other hand, it was also thought that defi-
ciencies in the host response could be at the basis of the rapid
periodontal destruction. Aggressive periodontitis was further
divided into a localized form (LAgP) typically affecting first
molars and incisors, and a more generalized form (GAgP), not
necessarily deriving from the former,1 but possibly expression of
a different pathogenic process. Although affecting a relatively
small proportion of the population compared with CP, the rapid-
ity of progression and high risk of tooth loss at a young age make
AgP a very unique and relevant disease.3 The next sections will
review the evidence to accept or reject the notion that AgP has a
distinct microbiological pathogenesis from CP and to help decide
whether microbiological or host response factors are more to
blame for its onset and progression.
AgP- Microbiological Studies
The first term used to define cases of early-onset destructive
periodontal diseases was “periodontosis.”4 This should perhaps
not surprise us, since no clear “inflammation” element can be
macroscopically distinguished in many of these cases, with dis-
proportionate periodontal destruction compared with the
amount of local deposits, especially in LAgP cases.5 Hence, the
emphasis was on a possible degenerative disease leading to bone
resorption and tooth mobility. While the 1960s brought the evi-
dence to confirm that dental plaque is the etiological factor of
periodontal diseases,6,7 crucial studies in the 1970s investigated a
possible microbiological cause of what we now call AgP. As
“non-specific”8 and then “specific”9 plaque hypotheses for peri-
odontitis developed, it was now becoming clear that AgP was
also a plaque-induced gingival disease. Listgarten, by light and
electron microscope analysis of teeth extracted from
“periodontosis” cases, identified “small clumps of Gram-negative
coccoid bacteria and neutrophils in varying stages
of disintegration.” He also observed fewer morphologic forms
compared with CP.10 Newman and co-workers detected
© Luigi Nibali
*Correspondence to: Luigi Nibali; Email: l.nibali@ucl.ac.uk
Submitted: 09/22/2014; Revised: 11/06/2014; Accepted: 01/06/2014
http://dx.doi.org/10.4161/21505594.2014.986407
This is an Open Access article distributed under the terms of the Creative
Commons Attribution-Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,
distribution, and reproduction in any medium, provided the original work is
properly cited. The moral rights of the named author(s) have been asserted.
www.tandfonline.com 223Virulence
Virulence 6:3, 223--228; April 2015; Published with license by Taylor & Francis Group, LLC
REVIEW
Gram- anaerobic bacteria including Bacteroides, Campilobacter,
Selenomonas, Fusobacterium with an additional 45% not identi-
fied.11 A milestone in the microbial studies on AgP came with
the discovery of the role of A. actinomycetemcomitans, found to
have pathogenic abilities and characteristics which allowed its
inclusion as a periodontal pathogenic bacterium.12 In a large
study in the United States, A. actinomycetemcomitans was detected
in nearly all the analyzed LAgP patients, and in contrast in fewer
healthy (16.9%) or chronic periodontitis subjects (20.8%) as
assessed by culture and immunofluorescence serotyping.13 A
more established role for A. actinomycetemcomitans became
clearer with the evidence of a correlation of its elimination with
treatment response 14 and the finding of an elevated serum anti-
body response to this bacterium in patients with LAgP.15,16 The
next milestone was represented by the discovery, in a young case
of LAgP, of the A. actinomycetemcomitans JP2 clone,17 character-
ized by a 530-base-pair deletion in the leukotoxin operon, associ-
ated with increased leukotoxic activity.18 A different pathogenic
potential was also identified across the various A. actinomycetem-
comitans serotypes.19 A. actinomycetemcomitans has shown clear
association with onset of AgP in a 1-year prospective study in the
United States, where patients with detectable A. actinomycetemco-
mitans at baseline had a higher risk of developing AgP compared
with matched subjects who did not harbor it. In particular, 8 out
of 38 A. actinomycetemcomitans-positive and none of 58 A. actino-
mycetemcomitans-negative subjects exhibited bone loss at the last
study follow-up.20 A similar association was found in a 15-year
longitudinal study in Indonesian adolescents and young adults,21
while no predictive role for A. actinomycetemcomitans in disease
progression was found in a German study on 105 young male
soldiers followed up for 1 year.22 A prospective study in a Moroc-
can population of 428 adolescents showed a strong association
between the JP2 clone and periodontal attachment loss over a
2-year period.23 A more recently-published longitudinal study
on nearly 400 Ghanaian adolescents showed a similar association
between detection of the JP2 clone and attachment loss over
2 years.24 Interestingly, also detection of highly leukotoxic non-
JP2 A. actinomycetemcomitans clones was associated with
increased diseased progression risk.25
However, it also clearly emerged that A. actinomycetemcomi-
tans is not universally detected in AgP sites 26 and cases 27 and it
is also found in healthy individuals 28 and in healthy sites of dis-
eased individuals.29 Furthermore, studies have often shown to
have a similar prevalence of detection in AgP and CP cases.30
Hence, A. actinomycetemcomitans, but also P. gingivalis, are cer-
tainly not the only possible pathogens predisposing to AgP.
Recent technological advances have led to an improvement in
microbiological detection techniques and metagenomic studies
in AgP are starting to suggest the possible role of non-cultivable
microbes in its pathogenesis.19 Among putative pathogens, based
on increased detection in AgP vs. periodontal health, Filifactor
alocis,31 Centipeda genus,32 Mitsuokella sp.,33 Selenomonas genus,32
Actinobacter baumannii,34 Treponema lecithinolyticum35 and even
the Archaea domain 36 are emerging as associated with AgP.
Their potential pathogenic role still needs to be elucidated and
scrutinized based on Socransky’s criteria,12 once more literature
data become available. Nonetheless, a more variegated picture of
AgP-pathogenic bacteria is emerging, which has to be carefully
kept in mind in future research. In balance, it seems clear that A.
actinomycetemcomitans (and particularly the JP2 clone) plays a
role in the pathogenesis of AgP, especially LAgP. However, it
may be possible that A. actinomycetemcomitans plays a strong role
in disease initiation and is then replaced by other pathogenic bac-
teria, presumably obligate anaerobic, as the disease progresses.37
The Differential Microbiological Profile of AgP
and CP
As we endeavor to understand pathogenic and clinical differen-
ces between aggressive and chronic periodontitis, hoping to design
more targeted management regimes for these conditions, an inter-
esting insight is given by studies comparing the microbiology of
AgP and CP. A systematic review over a decade ago concluded
that detection of A. actinomycetemcomitans or P. gingivalis was not
enough to discriminate between AgP and CP. In other words,
albeit AgP cases were found to harbor A. actinomycetemcomitans
with higher frequency than CP cases (62% vs. 28%), detection of
these bacteria could not be used as a diagnostic criterion. During
the last decade, even more studies have cast doubts on a different
microbial profile between AgP and CP. Whether due to limita-
tions in the microbiological techniques used or simply to our
inability to clinically distinguish certain cases of AgP from CP, no
differences in subgingival microbial detection emerged in several
studies.35,37,38,40 We recently reported results of a study on poly-
merase chain reaction (PCR) detection of A. actinomycetemcomi-
tans or P. gingivalis from subgingival plaque samples of 267
periodontitis patients (84 diagnosed with AgP and 183 with
CP).30 In this patient sample, CP cases had higher detection of
both bacteria compared with AgP, although the differences were
not statistically significant. However, this study did not provide
quantitative measures of these bacteria subgingivally. Quantitative
data on numbers of subgingival bacteria, different serotypes or
clones and uncultivable microbes will certainly shed further light
into the differential microbial profile of AgP and CP.
The Host Response in AgP
A substantial body of evidence has accumulated to suggest
large inter-individual variations in the response to dental plaque
accumulation, leading to different degrees of gingival inflamma-
tion.41 In line with this concept, already from the initial attempts
into research on early onset forms of periodontitis, it became
apparent that affected individuals suffered from a metabolic
imbalance or from inherited host response defects.2,42 The first
line of periodontal defense is provided by the innate immune
response, in the form of neutrophils and macrophages, fibro-
blasts, epithelial and dendritic cells, which are normally continu-
ously engaged in responses to bacterial plaque in a state of pre-
clinical “physiological” inflammation.43 When this response is
not able to control microbial accumulation, complex
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inflammatory cascades are activated and an adaptive immune
response is called upon by antigen-presenting cells, with a pro-
gressive shift from a predominantly T-cell lesion to a B-cell dom-
inated lesion typical of periodontitis.43 As evidence of presence
of neutrophils in gingival lesions and in root surfaces of AgP cases
accumulated,44,45 it emerged that neutrophils of AgP patients
could be responsible for disease predisposition due to an array of
suspected malfunctions, including increased adhesion, reduced
chemotaxis, increased superoxide and nitric oxide production
and reduced phagocytosis.46-49 These neutrophil features would
make individuals more susceptible to periodontitis upon subgin-
gival microbial colonization. The 1999 Workshop also suggested
among secondary features of AgP ‘Hyper-responsive macrophage
phenotype, including elevated levels of prostaglandin E2 (PGE2)
and interleukin (IL)-1b’.5 Recently, an excessive local and sys-
temic inflammatory response has been reported in AgP cases, spe-
cific to macrophage inflammatory protein (MIP)-1a 50 and to
response to bacterial endotoxin in LAgP.51 A recent study investi-
gated antibody response to periodontopathogenic bacteria in 119
patients (18 LAgP, 37 GAgP, 37 LCP, 27 GCP). Subgingival
plaque samples were analyzed by checkerboard for 11 bacterial
species, serum immunoglobulin G (IgG) levels against the same
bacteria were investigated and ‘infection ratios’ (antibody level
over the average bacterial colonization) were calculated for each
patient. Interestingly, no differences in serum IgG levels to A.
actinomycetemcomitans were detected. IgG levels to several species
including P. gingivalis, Treponema denticola and Campilobacter
rectus were highest in GAgP patients and significantly different
from LCP and generalized CP, but not from LAgP. No differen-
ces in ’infection ratios’ between GAgP and LAgP were detected,
bringing evidence against the ‘weak serum antibody responses’ in
GAgP patients. The authors concluded that serum IgG responses
in GAgP are comparable to those in LAgP, but higher than in
GCP or LCP for several species.52 However, it is important to
point out that antibody responses are time-related and a positive
titer may just indicate previous rather than necessarily present
exposure.
Interestingly, even treated AgP cases exhibited an enhanced
inflammatory response in an experimental gingivitis model, sug-
gesting a possible constitutive hyper-inflammatory status.53
These clues lead to the understanding that, if chronically acti-
vated by certain microbial triggers, the host response could con-
tribute to the extensive rapid tissue damage to the periodontium
seen in these cases. Genetic studies investigating heritable AgP
traits have focused on putative host response genotypes, which
would cause constitutive neutrophil abnormalities or dysfunc-
tions in other inflammatory/immune response pathways. Enthu-
siasm gained from linkage analyses and from the observation of
single-gene defects leading to early onset forms of periodontitis
has been dampened by the reality that AgP encompasses a large
range of conditions clinically undistinguishable but possibly with
different initiating factors. For example, the cathepsin C defects
leading to a non-syndromic form of early onset periodontitis
only affect a very small subpopulation of AgP cases.54 Equally,
the chromosome loci suggested by two separate genetic linkage
studies 55,56 may indeed predispose to AgP, but probably just in
some sporadic cases or families. Promising putative single nucleo-
tide polymorphisms (SNPs) recently identified in genome-wide
studies in the GLT6D1 and vitamin C transporter SVCT1 genes
may increase the susceptibility to AgP57,58 in a complex genetic
susceptibility profile interacting with environmental factors. Eth-
nic variations in the susceptibility to AgP and CP also need to be
considered, as they have a strong impact on observed genetic
associations (which change across different ethnic groups).
Among other genetic variants, pro-inflammatory Interleukin
(IL)-6 single nucleotide polymorphisms (SNP) 59 may act as risk
modifiers by increasing the inflammatory potential upon micro-
bial insults.60 A moderate association between IL-6 genetic var-
iants and increased detection of A. actinomycetemcomitans has
been repeatedly shown in different periodontitis populations
(both AgP and CP) by this author 12,61,62 and others,63 under-
scoring the concept of infectogenomics and genetic dysbiosis.64
In a study on 12 AgP patients selected based on their IL6 geno-
types, we detected higher A. actinomycetemcomitans counts in IL6
‘haplotype positive’ subjects before treatment. Despite a reduc-
tion after treatment, these subjects tended to have a sharp
increase in counts of A. actinomycetemcomitans again at the last
study follow-up, 3 months after periodontal surgery, suggesting a
strong genetic influence on pocket re-colonization.65 Further
examples of interactions between host genetic and microbial fac-
tors in AgP can be found in the A. actinomycetemcimitans-leuko-
toxin activation and secretion of bioactive IL-1b and IL-18 by
human macrophages,66 which might act in synergy with the IL-
1b polymorphism to cause an imbalance in the host response.
Recently, gene expression analyses of gingival biopsies from 55
AgP cases identified overexpressed genes related to immune
responses (esp B cells and Nk cells), apoptosis, and signal trans-
duction when compared with gingival samples from 65 CP
patients.67 This suggests some possible differences in pathogenic
pathways between AgP and CP. However, studies investigating
differences between AgP and CP identified no evidence of differ-
ences in the inflammatory infiltrate 68 or in the cells and processes
involved, only suspecting a possibly different shift from T-cell to
B-cell lesion in AgP compared with CP.69
A compelling example of early onset periodontal destruction
is given by localized aggressive periodontitis (LAgP), character-
ized by a circumpubertal onset and a strong antibody response
to periodontal pathogenic bacteria.5 LAgP affects first molars
and incisors, the first teeth to erupt in the mouth at age 6–8.
The disease progresses very rapidly, with periodontal attachment
and alveolar bone loss but then it often stops even in the
absence of therapy,70 suggesting a possible host response adapta-
tion or the mounting of an effective and ‘mature’ antibody
response to pathogenic bacteria.71,72 Cementum hypoplasia and
a possible role of Cytomegalovirus infection during root forma-
tion (causing malformation of attachment apparatus) have been
hypothesized as a possible cause of LAgP.73,74 However, evi-
dence for a possible role of viruses in AgP is still controversial.75
Furthermore, owing to its relative rarity, not many investiga-
tions on LAgP have been produced in the literature especially




Subjects affected by AgP seem to suffer from a ‘primed’ host
response status particularly susceptible to certain microbial trig-
gers.53 Within this context, in line with the polymicrobial syn-
ergy and dysbiosis hypothesis,76,77 potential keystone
periodontal pathogens could lead to disruption of tissue homeo-
stasis and the subsequent dysbiotic change in the subgingival bio-
film may induce AgP. For instance, ‘hyper-inflammatory’
genotypes (as in IL-1 or IL-6 hyper-producers)59,78 might predis-
pose to subgingival environments more conducive to the growth
of bacteria which grow well in more inflamed area such as A. acti-
nomycetemcomitans. This is still a theory, but is substantiated by
the association between IL6 genotypes and detection of A. actino-
mycetemcomitans and re-colonization with this bacterium follow-
ing periodontal treatment.30,61,62,65 The subgingival presence
and pathogenic relevance of specific bacteria and strains such as
A. actinomycetemcomitans JP2 clone is probably modulated by
age but is under a strong host genetic influence, as testified by the
prevalence of this clone in people of specific ethnicity, not neces-
sarily dependent on their geographic origin.79,80 The JP2 has
shown strong evidence of association with disease initiation and
progression.20,23 This association seems more evident than previ-
ously-reported associations between bacteria such as P. gingivalis
and T. denticola and progression of chronic periodontitis.81,82
However, the jury is still out on whether JP2 clone may work as
a classical exogenous bacterium or if it is involved in a dysbiotic
process. Hence, host genetic variants may be responsible for the
dysbiotic process or for an altered response to dysbiotic changes
and cooperate with keystone bacteria and environmental factors
in the onset and progression of AgP. However, it has to be borne
in mind that AgP probably covers a range of etiologically diverse
but clinically undistinguishable entities originating from a com-
plex web of interactions between microbiological and host
response factors.
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